Compare Illumina, Inc. (ILMN) vs Block Inc (XYZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Block Inc — how do they compare? Illumina, Inc. trades at $189.99 (market cap $27.94B), while Block Inc trades at $80.44 (market cap $47.19B). The key difference: Block Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ILMN | XYZ | |
|---|---|---|
Market Cap | $27.94B | $47.19B |
Sector | Health | Technology |
52-Week High | $194.33 | $81.81 |
52-Week Low | $91.00 | $49.04 |
Enterprise Value | $29.33B | $42.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Block (XYZ) trades at $79.72, down 0.28% on the day, with strong technical momentum as moving averages signal bullish sentiment. The company reported mixed Q1 2026 earnings, beating expectations with $0.85 EPS versus $0.675 forecast, while revenue reached $24.19 billion in 2025. Recent news highlights include a $45 million settlement over Cash App fraud allegations and continued strength in Square and Cash App segments.
The stock offers 12% upside to the $89.53 consensus price target, supported by 74% analyst buy ratings. However, elevated P/E of 62.45 and declining net income margins from 12.01% to 5.39% pose valuation concerns. Key risks include rising credit losses and regulatory scrutiny, while AI integration and payment growth present long-term opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →
